Healthcare -
Biotechnology - NASDAQ - US
$ 279.01
0.667 %
$ 36 B
Market Cap
-106.09
P/E
ALNY - INTEREST INCOME & EXPENSE
Interest Income & Expense ALNY - Alnylam Pharmaceuticals, Inc.
121 M
LAST VALUE
-7.94%
2 YEAR CAGR
32.88%
5 YEAR CAGR
60.49%
10 YEAR CAGR